News Information

Chairman Wu Xiukun was invited to attend the "Golden Enterprise Business Path" financial policy interpretation meeting to assist enterprises.


Release time:

2022-03-09

Chairman Wu Xiukun was invited to attend the "Golden Enterprise Business Path" financial policy interpretation meeting to assist enterprises.

On March 2, 2022, the Jinwan District General Chamber of Commerce held the second event of the 2022 "Golden Enterprise Business Path" series - a meeting to interpret new financial policies to assist enterprises. Chairman Wu Xiukun was invited to attend this meeting.

Chairman Wu Xiukun stated that traditional Chinese medicine is entering the best development opportunity. The new financial policies introduced in Jinwan District will promote the rapid development of traditional Chinese medicine enterprises. Zhuhai Miditech Biopharmaceuticals focuses on the research and production of traditional Chinese medicine anti-tumor drugs. Its patented product for treating liver cancer and cirrhosis, Sanjie Pian, has obtained the National Drug Approval Number; its patented product for treating lung cancer and nasopharyngeal cancer, Baishan Pian, has obtained clinical approval. This year, six health products will also be launched. Of course, we have the largest traditional Chinese medicine pre-processing workshop in Zhuhai, which can provide services for many enterprises that need to extract traditional Chinese medicine; we also provide commissioned processing services for functional foods with recipes that have both medicinal and food origins. After the meeting, several financial institutions expressed strong interest in Miditech's traditional Chinese medicine anti-tumor project and stated that they would further deepen their understanding of the enterprise to provide financing for the development of traditional Chinese medicine.

Lin Weiping, Deputy Minister of the United Front Work Department of the District Committee, Secretary of the Party Leadership Group of the District Federation of Industry and Commerce, and Executive Vice President of the District General Chamber of Commerce, attended the event and delivered a speech. The lectures by the Jinwan District Financial Service Center and the Investment Banking Department of GF Securities were insightful and engaging, with vivid and lively case studies, which had a strong inspiring effect.

Related Information

Anti-liver cancer and liver cirrhosis traditional Chinese medicine - Sanjie Pian, safeguarding 447 million chronic liver disease patients.

Traditional Chinese Medicine for Liver Cancer and Liver Cirrhosis - Sanjie Pian, safeguarding 447 million chronic liver disease patients.

See more →

The research and development achievements of the anti-liver cancer traditional Chinese medicine - Sanjie Pian have been included in the "National Science and Technology Achievements Database."

In 2021, the anti-liver cancer traditional Chinese medicine - Sanjie Pian passed the expert review by the Ministry of Science and Technology, achieving a level of technological advancement that is considered leading in the country. The research and development results have been included in the National Science and Technology Achievements Database (No. 6012021Y0389). It was publicly announced on the National Science and Technology Achievements Registration Work Platform (Guokewang) in March 2022.

See more →